Caitong International Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Caitong International Asset Management's BIIB Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in Biogen (BIIB) in Q2 2026: 14 shares worth $3.02K. The stake represents ﹤0.01% of the portfolio and ranks #1351 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in BIIB as recently as Q3 2025.
Caitong International Asset Management first reported a position in BIIB in Q4 2024 and has held it in 4 quarters since. The position peaked at $61.3K in Q1 2025. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Caitong International Asset Management held 14 shares of Biogen worth $3.02K as of Q2 2026.
- Biogen was a new Caitong International Asset Management position in Q2 2026.
- Biogen made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1351 holding.
- Caitong International Asset Management first reported a position in Biogen in Q4 2024 and has held it in 4 quarters since.
- Caitong International Asset Management's Biogen position peaked at $61.3K in Q1 2025.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.